Literature DB >> 2335508

Binding characteristics of galactoside-binding lectin (galaptin) from human spleen.

R T Lee1, Y Ichikawa, H J Allen, Y C Lee.   

Abstract

Binding characteristics of human spleen soluble galactoside-binding protein (galaptin) were studied using simple galactosides, galactose-terminated disaccharides, cluster glycosides containing up to 6 terminal lactosyl residues, bovine serum albumin derivatives containing 7 to 40 lactosyl residues, desialylated serum glycoproteins, and glycopeptides derived thereof as inhibitors in a newly developed binding assay. In this assay, aminohexyl lactoside was attached to divinyl sulfone-activated Sepharose, which was then used to bind 125I-galaptin. Similarly derivatized Sepharose containing mannoside served as a control. The assay is sensitive, maintains linearity in the concentration range of 125I-galaptin tested, and has very low nonspecific binding. The following new findings were made. 1) All the alpha-D-galactopyranosides with non-sugar aglycon were better inhibitors than the corresponding beta-D-galactopyranoside. 2) The S-galactosides were better inhibitors than the corresponding O-galactosides, regardless of the anomeric configuration. 3) Many Gal beta 1-4- and Gal beta 1-3-linked disaccharides were tested. Although the galaptin did not appear to recognize N-acetylglucosamine as a monosaccharide, the presence of this sugar penultimate to galactose increased the binding affinity by as much as 500-fold, as was the case for N-acetyllactosamine. Of a particular importance is the presence of an equatorial 3-OH group on this sugar. We synthesized the 3-deoxy derivative of N-acetyllactosamine and found that it had 50-fold lower binding affinity compared to N-acetyllactosamine. 4) The binding sites of this lectin do not seem to be operating in a cooperative fashion, since synthetic lactose-containing divalent ligands with various inter-galactose distances did not increase the binding affinity significantly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Affinity enhancement by multivalent lectin-carbohydrate interaction.

Authors:  R T Lee; Y C Lee
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

2.  Lectin-mediated drug targeting: selection of valency, sugar type (Gal/Lac), and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectins.

Authors:  S André; B Frisch; H Kaltner; D L Desouza; F Schuber; H J Gabius
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

Review 3.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 4.  Introduction to galectins.

Authors:  Hakon Leffler; Susanne Carlsson; Maria Hedlund; Yuning Qian; Francoise Poirier
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 5.  Galectin-1 research in T cell immunity: past, present and future.

Authors:  Filiberto Cedeno-Laurent; Charles J Dimitroff
Journal:  Clin Immunol       Date:  2011-10-06       Impact factor: 3.969

6.  Binding of synthetic sulfated ligands by human splenic galectin 1, a beta-galactoside-binding lectin.

Authors:  H J Allen; H Ahmed; K L Matta
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

7.  Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis.

Authors:  C Hafer-Macko; M Pang; J J Seilhamer; L G Baum
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

8.  Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue.

Authors:  B Woynarowska; C J Dimitroff; M Sharma; K L Matta; R J Bernacki
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

9.  Cell type-dependent alterations of binding of synthetic blood group antigen-related oligosaccharides in lung cancer.

Authors:  K Kayser; N V Bovin; T V Zemlyanukhina; S Donaldo-Jacinto; J Koopmann; H J Gabius
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

10.  Energetics of carbohydrate binding by a 14 kDa S-type mammalian lectin.

Authors:  R Ramkumar; A Surolia; S K Podder
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.